StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note published on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $7.00 price objective on shares of TRACON Pharmaceuticals in a research report on Monday, November […]
Related Keywords
United States , , York Mellon Corp , Pharmaceuticals Inc , Millennium Management , Virtu Financial , Pharmaceuticals Daily , Renaissance Technologies , Nasdaq , Pharmaceuticals Stock Performance , Free Report , Get Free Report , New York Mellon Corp , Street Group , Tracon Pharmaceuticals , Nasdaq Tcon , Ltcon , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.